Anti-osteoporotic activity of puerarin 6″-O-xyloside on ovariectomized mice and its potential mechanism

References

• Bereswill S, Munoz1 M, Fischer A, et al. (2010). Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5:e15099
   PubMed Web of Science ®Google Scholar
• Bock O, Felsenberg D. (2008). Bisphosphonates in the management of postmenopausal osteoporosis-optimizing efficacy in clinical practice. Clin Interv Aging 3:279–97
   PubMed Web of Science ®Google Scholar
• Canalis H, McCarthy T, Centrella M. (1998). Growth factors and the regulation on bone remodeling. J Clin Invest 81:277–81
   Web of Science ®Google Scholar
• Chin KY, Ima-Nirwana S. (2013). Can soy prevent male osteoporosis? A review of the current evidence. Curr Drug Targets 14:1632–41
   PubMed Web of Science ®Google Scholar
• Du J, Wei YJ, Peng C, et al. (2011). Establishment of a luciferase assay-based screening system for detecting estrogen receptor agonists in plant extracts. Bone 49:572–9
   PubMed Web of Science ®Google Scholar
• Genant HK, Bay DJ, Gallagher JC. (1998). Estrogens in the prevention of osteoporosis in post menopausal women. Am J Obstet Gynecol 161:1842–6
   Google Scholar
• Ishida H, Uesugi T, Hirai K, et al. (1998). Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21:62–6
   PubMed Web of Science ®Google Scholar
• Jia L, Cao DP, Qin LP, et al. (2009). Antiosteoporotic activity of phenolic compounds from Curculigo orchioides. Phytomedicine 16:874–81
   PubMed Web of Science ®Google Scholar
• Kalu DN. (1991). The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175–91
   PubMedGoogle Scholar
• Li F, Yang XL, Yang YN, et al. (2013). Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine 20:549–57
   PubMed Web of Science ®Google Scholar
• Li H, Wang JH, Huang HL, Li B. (2011). Puerarin combined with estradiol for treatment of osteoporosis in ovariectomized rats. J Clin Rehab Tiss Eng Res 15:8698–701
   Google Scholar
• Li JWH, Vederas JC. (2009). Drug discovery and natural products: End of an era or an endless frontier? Science 325:161–5.
   PubMed Web of Science ®Google Scholar
• Liu XH, Kirschenbaum A, Yao S, Levine AC. (2005). Crosstalk between the interleukin-6 and prostaglandin E2 signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-κB (RANK) ligand/RANK system. Endocrinology 146:1991–8
   PubMed Web of Science ®Google Scholar
• Liu ZD, Zang HS, Ou-Yang YP. (1995). Biological study of growth pattern of newborn rat calvaria osteoblastic cell in vitro. Acta Anatom Sin 26:157–9
   Google Scholar
• Ma XQ, Zheng CJ, Zhang Y, et al. (2013). Antiosteoporotic flavonoids from Podocarpium podocarpum. Phytochem Lett 6:118–22
   Web of Science ®Google Scholar
• Nian H, Ma MH, Nian SS, Xu L. (2009). Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 16:320–6
   PubMed Web of Science ®Google Scholar
• Nian H, Qin LP. (2006). Antiosteoporotic activity of Er-Xian decoction, a traditional Chinese herbal formula, in ovariectomized rats. J Ethnopharmacol 108:96–102
   PubMed Web of Science ®Google Scholar
• Peng W, Ming QL, Han P, et al. (2014). Anti-allergic rhinitis effect of caffeoylxanthiazonoside isolated from fruits of Xanthium strumarium L. in rodent animals. Phytomedicine 15:824–9
   Web of Science ®Google Scholar
• Qin LP, Han T, Zhang QY, et al. (2008). Antiosteoporotic chemical constituents from Er-Xian decoction, a traditional Chinese herbal formula. J Ethnopharmacol 118:271–9
   PubMed Web of Science ®Google Scholar
• Riggs BL, Melton LJ. (1986). Involutional osteoporosis. New Engl J Med 314:1676–86
   PubMed Web of Science ®Google Scholar
• Steeve KT, Marc P, Sandrine T, et al. (2004). IL-6, RANKL, TNF-α/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49–60
   PubMed Web of Science ®Google Scholar
• Tüzün S, Akyüz G, Eskiyurt N, et al. (2013). Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: A randomized controlled study. Int J Mol Sci 10:1880–7
   Web of Science ®Google Scholar
• Wang Y, Wang WL, Xie WL, et al. (2013). Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK andPI3K/Akt activation. Phytomedicine 20:787–96
   PubMed Web of Science ®Google Scholar
• Xue LM, Jiao L, Wang Y, et al. (2012). Effects and interaction of icariin, curculigoside, and berberine in Er-Xian decoction, a traditional Chinese Medicinal formula, on osteoclastic bone resorption. Evid Based Complement Alternat Med 2012:490843
   PubMedGoogle Scholar
• Zhang H, Xing WW, Li YS, et al. (2008). Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts. Maturitas 61:334–9
   PubMed Web of Science ®Google Scholar
• Zheng GL, Zhang XY, Meng QH, Gong WG. (2002). Protective effect of total isoflavones from pueraria lobata on secondary osteoporosis induced by dexamethasone in rats. J Chin Med Mater 25:643–6
   Google Scholar
• Zhu Z, Xue LM, Han T, et al. (2010). Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7. Molecules 15:4695–710
   PubMed Web of Science ®Google Scholar